Low incidence of early postoperative cerebral edema after coronary artery bypass grafting

Thomas H Ottens1, Jeroen Hendrikse2, Arjen J C Slooter3

  • 1Departments of Anesthesiology.

Insights

High-dose dexamethasone did not significantly reduce early cerebral edema after coronary artery bypass grafting (CABG). Postoperative brain swelling was minimal in both dexamethasone and placebo groups, contrary to previous findings.

Area of Science:

  • Neurosurgery
  • Cardiology
  • Pharmacology

Background:

  • Coronary artery bypass grafting (CABG) can lead to early postoperative cerebral edema.
  • Intraoperative dexamethasone is hypothesized to mitigate this complication.

Purpose of the Study:

  • To investigate the effect of a single high dose of intraoperative dexamethasone on early cerebral edema after CABG using magnetic resonance imaging (MRI).

Main Methods:

  • A secondary analysis of the Dexamethasone for Cardiac Surgery (DECS) trial involving 20 adult patients undergoing CABG with cardiopulmonary bypass.
  • Patients received either a high dose of dexamethasone (1 mg/kg) or placebo intravenously at anesthesia induction.
  • Cerebral edema severity was assessed immediately post-surgery via MRI.

Main Results:

  • Only 1 patient in the dexamethasone group exhibited slight cerebral edema, compared to none in the placebo group (p=1.00).
  • No significant difference in the severity of cerebral edema was observed between the dexamethasone and placebo groups (p=1.00).
  • Median cardiopulmonary bypass time was 66 minutes for dexamethasone and 95 minutes for placebo (p=0.11).

Conclusions:

  • The study did not observe significant early postoperative cerebral edema in patients undergoing CABG, regardless of dexamethasone administration.
  • These findings contrast with older studies that reported a higher incidence of cerebral edema post-CABG.
Abstract